 |
PDBe Entry: 2nnj 
CYP2C8dH complexed with felodipine
 |
OXIDOREDUCTASE,ELECTRON TRANSPORT
|
|
X-RAY DIFFRACTION
|
|
Resolution: 2.28 Å, R-factor: 24.0%, Free R-factor: 27.0%, Spacegroup: I 2 2 2
|
|
23/10/2007, deposition: 24/10/2006, last revision: 09/06/2009
|
Schoch, G.A. ; Yano, J.K. ; Stout, C.D. ; Johnson, E.F.
|
Determinants of cytochrome P450 2C8 substrate binding: structures of complexes with montelukast, troglitazone, felodipine, and 9-cis-retinoic acid. J.BIOL.CHEM. vol:283, pag:17227-17237 (2008) [PubMed ID 18413310 ]
|
CYP2C8; Human P450 2C8; monooxygenases; Felodipine; Plendil; inhibitor complex; palmitic acid , OXIDOREDUCTASE , ELECTRON TRANSPORT
|
1.14.14.1 ExPASy BRENDA (A)
|
Homo sapiens(human) 9606 (A)
|
Cytochrome P450 2C8 (EC 1.14.14.1) (CYPIIC8) (P450 form 1) (P450 MP-12/MP-20) (P450 IIC2) (S-mephenytoin 4-hydroxylase) P10632 (A)
|
|
A
|
|
2nnh, 2nni
|
| A |
Cytochrome P450 2C8 |
Protein |
P10632 (CP2C8_HUMAN)
|
476 |
97% |
|
| A |
SULFATE ION |
SO4
 |
| A |
PROTOPORPHYRIN IX CONTAINING FE |
HEM
 |
| A |
FELODIPINE |
225
 |
| A |
PALMITIC ACID |
PLM
 |
|
|